Evidence map›Paper›PMID 34981769›Full record

ArticleActa crystallographica. Section F, Structural biology communications2022

The crystal structure of DynF from the dynemicin-biosynthesis pathway of Micromonospora chersina.

Abigael J Kosgei, Mitchell D Miller, Minakshi Bhardwaj, Weijun Xu, Jon S Thorson, Steven G Van Lanen, George N Phillips

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abigael J KosgeiDepartment of Biosciences, Rice University, Houston, TX 77251, USA.
Mitchell D MillerDepartment of Biosciences, Rice University, Houston, TX 77251, USA.ORCID 0000-0003-1626-4943
Minakshi BhardwajDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40506, USA.
Weijun XuDepartment of Biosciences, Rice University, Houston, TX 77251, USA.
Jon S ThorsonDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40506, USA.ORCID 0000-0002-7148-0721
Steven G Van LanenDepartment of Biosciences, Rice University, Houston, TX 77251, USA.
George N PhillipsDepartment of Biosciences, Rice University, Houston, TX 77251, USA.ORCID 0000-0002-4171-4603

Funding

User Training & OutreachP30GM138396 · NIGMS · UCHICAGO ARGONNE, LLC · PI ROBERT F. FISCHETTI · 2020 to 2026
$34.3M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular diseaseP20GM130456 · NIGMS · UNIVERSITY OF KENTUCKY · PI Jon Scott Thorson · 2020 to 2026
$18.7M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Studies to understand and exploit 10-membered enediyne biosynthesisR01CA217255 · NCI · UNIVERSITY OF KENTUCKY · PI PHILLIPS, GEORGE NEAL, THORSON, JON SCOTT · 2017 to 2021
$2.6M
Platform technologies for understanding and exploiting methylationR01GM115261 · NIGMS · UNIVERSITY OF KENTUCKY · PI PHILLIPS, GEORGE NEAL, THORSON, JON SCOTT · 2016 to 2019
$2.2M
National Institutes of Health, National Institute of General Medical Sciences RO1 GM115261National Science Foundation, BioXFEL Science and Technology Center 1231306NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NCI NIH HHS R01 CA217255NIGMS NIH HHS P20 GM130456NIGMS NIH HHS P30 GM138396NIGMS NIH HHS R01 GM115261
6 · The paper itself

Abstract

Dynemicin is an enediyne natural product from Micromonospora chersina ATCC53710. Access to the biosynthetic gene cluster of dynemicin has enabled the in vitro study of gene products within the cluster to decipher their roles in assembling this unique molecule. This paper reports the crystal structure of DynF, the gene product of one of the genes within the biosynthetic gene cluster of dynemicin. DynF is revealed to be a dimeric eight-stranded β-barrel structure with palmitic acid bound within a cavity. The presence of palmitic acid suggests that DynF may be involved in binding the precursor polyene heptaene, which is central to the synthesis of the ten-membered ring of the enediyne core.

Indexed as

EnediynesMicromonosporaCrystallography, X-RayMultigene FamilyEnediynesanthraquinonebiosynthetic gene clustersdynemicinenediynesMicromonospora chersina ATCC53710natural productspolyketidesunknown functionβ-barrel

Identifiers

PMID34981769
PMCPMC8725005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.